Cocrystal Pharma
COCP
33 hedge funds and large institutions have $5.83M invested in Cocrystal Pharma in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 1.23% → 1.22% (-0.01%)
3% less funds holding
Funds holding: 34 → 33 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
26% less capital invested
Capital invested by funds: $7.9M → $5.83M (-$2.08M)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$123K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.7K |
| 3 |
Jane Street
New York
|
+$6.59K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$5.67K |
| 5 |
Goldman Sachs
New York
|
+$5.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$98.7K |
| 2 |
Morgan Stanley
New York
|
-$79.8K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$13K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9K |
| 5 |
VF
Virtu Financial
New York
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1K | – | – | – |
|
|
AIC
27
Archer Investment Corporation
Carmel,
Indiana
| $410 | – | – | – |
|
|
RJFSA
28
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | -$13K | -2,020 | Closed |
|
|
29
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$9K | -1,344 | Closed |
|
|
VF
30
Virtu Financial
New York
| – | -$8K | -1,186 | Closed |
|
31
Two Sigma Advisers
New York
| – | -$7K | -1,083 | Closed |
|
32
Wells Fargo
San Francisco,
California
| – | +$27 | +5 | +6% |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$43 | +8 | New |
|
|
HNB
34
Huntington National Bank
Columbus,
Ohio
| – | +$368 | +69 | New |
|
COCP Hedge Fund Activity: Q2 2022 in Review
33 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q2 2022, worth a combined $5.83M — down 26% from $7.9M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of COCP and 6 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 4 added.
The largest buyer was Sabby Management, adding an estimated $123K. The largest seller was BlackRock, cutting an estimated $98.7K.
- 33 institutional investors held Cocrystal Pharma (COCP) as of Q2 2022, down from 34 in Q1 2022.
- Funds reported $5.83M of Cocrystal Pharma stock for Q2 2022, down 26% quarter-over-quarter.
- 6 funds opened new Cocrystal Pharma positions in Q2 2022 and 7 closed out, a net change of -1 holder.
- The largest Cocrystal Pharma buyer in Q2 2022 was Sabby Management, an estimated $123K added.
- The largest Cocrystal Pharma seller in Q2 2022 was BlackRock, an estimated $98.7K sold.
Based on aggregated 13F filings for Q2 2022.